$25.900
-0.860 (-3.32%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
NAMS Prediction & Forecast by Similar Chart Analysis
Alphio's NAMS stock price prediction model matches the current NewAmsterdam Pharma Company NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $25.79 (-0.42%). The 1-week path is $27.01 (+4.29%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy NewAmsterdam Pharma Company NV Stock?
NewAmsterdam Pharma is currently not a strong buy due to its recent performance and financial losses, despite a positive analyst outlook. The current price is $25.9, with a significant year-to-date change of -26.42%. The RSI is at 27.88, indicating it is oversold, which could suggest a potential rebound. However, the company reported a widening net loss of $64.1 million in Q2, which raises concerns about its financial health. The main risk is the ongoing revenue decline, with an 80.7% year-over-year drop in Q2 revenue, which could hinder recovery efforts.
NAMS stock price ended at $25.90 on Friday, after losing -3.32%
NewAmsterdam Pharma Company NV (NAMS) last closed at $25.9, losing -3.32%. These facts feed the 1-day and 1-week NAMS price prediction above.
Forecast Drivers
NewAmsterdam Pharma Company NV (NAMS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches NAMS, ranked by similarity.
Seasonality analysis for NAMS
Historically the probability of a positive August return for NAMS is 34.92%. October offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for NAMS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $38.53 | $38.75 | $43.55 | +49.61% |
| Sep 2026 | $36.68 | $41.26 | $44.89 | +59.31% |
| Oct 2026 | $24.81 | $32.88 | $41.42 | +26.94% |
| Nov 2026 | $33.96 | $41.82 | $49.82 | +61.46% |
| Dec 2026 | $33.82 | $41.16 | $42.47 | +58.91% |
In 2026, NewAmsterdam Pharma Company NV (NAMS) is projected to range from $24.81 to $49.82.
NewAmsterdam Pharma Company NV 2026 monthly forecast
In Aug 2026, NewAmsterdam Pharma Company NV is projected to average $38.75, with a low of $38.53 and high of $43.55.
In Sep 2026, NewAmsterdam Pharma Company NV is projected to average $41.26, with a low of $36.68 and high of $44.89.
In Oct 2026, NewAmsterdam Pharma Company NV is projected to average $32.88, with a low of $24.81 and high of $41.42.
In Nov 2026, NewAmsterdam Pharma Company NV is projected to average $41.82, with a low of $33.96 and high of $49.82.
In Dec 2026, NewAmsterdam Pharma Company NV is projected to average $41.16, with a low of $33.82 and high of $42.47.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.